HT2 INFLUENCE OF HTA AND HOSPITAL FUNDING SYSTEMS ON PATIENT ACCESS TO INNOVATIVE MEDICINES: EXAMPLE OF ADVANCED RENAL CELL CANCER IN WESTERN EUROPE